Get the Stockscreener App
0.1005
5.68%
0.0054
Cero Therapeutics Holdings Inc stock is traded at $0.1005, with a volume of 8.44M.
It is up +5.68% in the last 24 hours and down -98.10% over the past month.
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
See More
Previous Close:
$0.0951
Open:
$0.117
24h Volume:
8.44M
Relative Volume:
7.92
Market Cap:
$121.14K
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-94.65%
1M Performance:
-98.10%
6M Performance:
-99.97%
1Y Performance:
-100.00%
1-Day Range:
$0.0931
$0.2089
1-Week Range:
$0.085
$1.86
52-Week Range:
$0.085
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Name
Cero Therapeutics Holdings Inc
Sector
Industry
Phone
650-407-2376
Address
201 HASKINS WAY, SOUTH SAN FRANCISCO
Compare CERO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
0.1005 | 177.38K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Upgrade | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Stock (CERO) Latest News
Using fundamentals and technicals on CERo Therapeutics Holdings Inc. Equity WarrantOil Prices & Risk Managed Investment Signals - newser.com
CERo Therapeutics (OTC: CERO) to show CER-1236 sustained expansion, cytokine response at SITC - Stock Titan
Real time breakdown of CERo Therapeutics Holdings Inc. Equity Warrant stock performanceWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
CERo Therapeutics Holdings Inc. Equity Warrant stock trendline breakdownM&A Rumor & Safe Capital Growth Stock Tips - newser.com
Multi asset correlation models including CERo Therapeutics Holdings Inc. Equity WarrantJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Why CERo Therapeutics Holdings Inc. stock is considered a top pickGold Moves & Safe Capital Allocation Plans - newser.com
Can CERo Therapeutics Holdings Inc. hit a new high this monthJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Is CERo Therapeutics Holdings Inc. still worth holding after the dipQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
Published on: 2025-11-04 01:19:45 - newser.com
What recovery options are there for CERo Therapeutics Holdings Inc.July 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
How CERo Therapeutics Holdings Inc. Equity Warrant stock reacts to job market dataMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
Short interest data insights for CERo Therapeutics Holdings Inc. Equity Warrant2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Why CERo Therapeutics Holdings Inc. stock is rated strong buyWeekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
CERO Downgraded to Hold by Maxim Group | CERO Stock News - GuruFocus
CERO SEC FilingsCERo Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Why CERo Therapeutics Holdings Inc. Equity Warrant stock remains on buy listsWeekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Is it too late to sell CERo Therapeutics Holdings Inc.July 2025 Highlights & Reliable Breakout Forecasts - newser.com
CERo Therapeutics Announces Listing on OTC Markets - The Manila Times
Evaluating CERo Therapeutics Holdings Inc. with trendline analysisMarket Movement Recap & Community Driven Trade Alerts - newser.com
What Fibonacci levels say about CERo Therapeutics Holdings Inc. reboundMarket Risk Summary & Daily Profit Focused Screening - newser.com
Why CERo Therapeutics Holdings Inc. stock is popular among millennialsQuarterly Earnings Summary & Precise Buy Zone Identification - newser.com
Why CERo Therapeutics Holdings Inc. Equity Warrant stock attracts global investors2025 Price Action Summary & Community Driven Trade Alerts - newser.com
How institutional ownership impacts CERo Therapeutics Holdings Inc. Equity Warrant stock2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-03 04:57:07 - newser.com
How CERo Therapeutics Holdings Inc. Equity Warrant stock trades before earningsEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Can CERo Therapeutics Holdings Inc. stock weather global recessionWeekly Trade Recap & Verified Momentum Watchlists - newser.com
What momentum shifts mean for CERo Therapeutics Holdings Inc.July 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
Will CERo Therapeutics Holdings Inc. stock recover faster than marketQuarterly Profit Review & Daily Oversold Bounce Ideas - newser.com
Applying Elliott Wave Theory to CERo Therapeutics Holdings Inc.Bull Run & Reliable Volume Spike Trade Alerts - newser.com
Using flow based indicators on CERo Therapeutics Holdings Inc.Earnings Growth Summary & Accurate Entry/Exit Alerts - newser.com
What machine learning models say about CERo Therapeutics Holdings Inc.2025 Trading Recap & Intraday High Probability Alerts - newser.com
How moving averages guide CERo Therapeutics Holdings Inc. tradingQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Published on: 2025-11-03 00:15:03 - newser.com
Can CERo Therapeutics Holdings Inc. Equity Warrant stock attract ESG capital inflowsBull Run & Real-Time Chart Breakout Alerts - newser.com
Can a trend reversal in CERo Therapeutics Holdings Inc. lead to recoveryJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com
Leading vs lagging indicators on CERo Therapeutics Holdings Inc. Equity Warrant performanceTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Is CERo Therapeutics Holdings Inc. Equity Warrant stock attractive for income investorsJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Using RSI to spot recovery in CERo Therapeutics Holdings Inc. Equity Warrant2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Identifying reversal signals in CERo Therapeutics Holdings Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com
Tools to assess CERo Therapeutics Holdings Inc.’s risk profileQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Analyzing recovery setups for CERo Therapeutics Holdings Inc. investorsJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Can swing trading help recover from CERo Therapeutics Holdings Inc. lossesMarket Activity Report & Entry Point Confirmation Signals - newser.com
Cero Therapeutics Holdings Inc Stock (CERO) Financials Data
There is no financial data for Cero Therapeutics Holdings Inc (CERO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Cero Therapeutics Holdings Inc Stock (CERO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| YK Bioventures Opportunities G | 10% Owner |
Dec 13 '24 |
Sale |
0.06 |
2,998,908 |
179,934 |
13,005,169 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 12 '24 |
Sale |
0.07 |
1,614,541 |
113,018 |
16,004,077 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 11 '24 |
Sale |
0.08 |
1,343,801 |
107,504 |
17,618,618 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 06 '24 |
Sale |
0.12 |
1,236,874 |
148,425 |
21,383,909 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 10 '24 |
Sale |
0.09 |
1,570,947 |
141,385 |
18,962,419 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 09 '24 |
Sale |
0.11 |
850,543 |
93,560 |
20,533,366 |
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):